US Funded Hepatitis B Trial Halted After Guinea Bissau Police Raids

Published 3d ago · Latest report 1d ago · Investigation

Affects United States and Guinea-Bissau · Covered in 2 countries

AI summary37s readNegative

A controversial US-backed newborn hepatitis B study in Guinea Bissau is halted after police raids and congressional scrutiny.

Lawmakers are questioning the Centers for Disease Control and Prevention over funding a disputed hepatitis B vaccine study in Guinea Bissau involving newborns. Police recently seized doses from the researchers leading the trial. The controversial project has now been officially halted following global backlash and law enforcement action.

The fundingThe Centers for Disease Control and Prevention awarded $1.6 million to Danish researchers last year.
The reactionHouse Democrats are demanding explanations regarding agency oversight of the foreign clinical trial.
The enforcementLocal authorities confiscated vaccine doses from researchers at the center of the dispute.

Why it matters

Clinical trials involving vulnerable populations abroad often face strict regulatory and ethical scrutiny. Congressional inquiries into federally funded international research help ensure transparency and accountability in public health spending.

Timeline3

Oct 20Police raided the offices of researchers in Guinea Bissau and seized vaccine doses.
Oct 21The lead researcher announced that the disputed hepatitis B vaccine trial would not move forward.
Oct 22House Democrats demanded answers from the Centers for Disease Control and Prevention over funding the study.

By the numbers1

$1.6Mstudy funding

How outlets cover it

What outlets agree on

The Centers for Disease Control and Prevention awarded funding for a hepatitis B clinical trial in Guinea Bissau that has now been halted following police intervention and lawmaker inquiries.

Tune your feed

Reactions